aspartic acid has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barolet, AW; Baskys, A; Bernstein, NK; Carlen, PL | 1 |
| Domańska-Janik, K; Zabøocka, B | 1 |
| Beart, PM; Bischof, L; Broberg, BV; Lau, CL; O'Shea, RD | 1 |
3 other study(ies) available for aspartic acid and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
| Article | Year |
|---|---|
NMDA and quisqualate reduce a Ca-dependent K+ current by a protein kinase-mediated mechanism.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aspartic Acid; Calcium; Enzyme Inhibitors; Hippocampus; Isoquinolines; Male; Membrane Potentials; N-Methylaspartate; Oxadiazoles; Piperazines; Potassium; Protein Kinases; Quisqualic Acid; Rats; Rats, Inbred F344; Second Messenger Systems | 1990 |
PAF antagonist, BN52021, inhibits [3H]D-aspartate release after ischaemia in vitro.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aspartic Acid; Brain Ischemia; Diterpenes; Enzyme Activation; Ginkgolides; Hippocampus; In Vitro Techniques; Isoquinolines; Lactones; Phorbol 12,13-Dibutyrate; Piperazines; Platelet Activating Factor; Potassium; Protein Kinase C; Rats; Rats, Wistar; Tritium | 1994 |
The Rho kinase inhibitor Fasudil up-regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Animals; Aspartic Acid; Astrocytes; Biological Transport; Cells, Cultured; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Glial Fibrillary Acidic Protein; Glutamic Acid; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Prosencephalon; rho-Associated Kinases; Up-Regulation | 2011 |